Review Explores Harms Linked to Antidepressant Treatment

Share this content:
Review Explores Harms Linked to Antidepressant Treatment
Review Explores Harms Linked to Antidepressant Treatment

THURSDAY, Jan. 28, 2016 (HealthDay News) -- The harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors cannot be estimated accurately, according to a review published online Jan. 27 in The BMJ.

Tarang Sharma, from the Nordic Cochrane Centre in Copenhagen, Denmark, and colleagues conducted a systematic review and meta-analysis to examine serious harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors. Data were included from clinical study reports and summary trial reports for duloxetine, fluoxetine, paroxetine, sertraline, and venlafaxine; 70 trials were included with 18,526 study patients.

The researchers identified limitations in the study design and discrepancies in reporting, correlating with underreporting of harms. There were no significant differences in mortality, suicidality, and akathisia (odds ratios [ORs], 1.28 [95 percent confidence interval (CI), 0.40 to 4.06]; 1.21 [95 percent CI, 0.84 to 1.74]; and 2.04 [95 percent CI, 0.93 to 4.48], respectively), but there was a significant difference for aggressive behavior (OR, 1.93; 95 percent CI, 1.26 to 2.95). The odds ratios for suicidality, aggression, and akathisia were 0.81 (95 percent CI, 0.51 to 1.28), 1.09 (95 percent CI, 0.55 to 2.14), and 2.00 (95 percent CI, 0.79 to 5.04), respectively, for adults. For children and adolescents, the corresponding values were 2.39 (95 percent CI, 1.31 to 4.33), 2.79 (95 percent CI, 1.62 to 4.81), and 2.15 (95 percent CI, 0.48 to 9.65).

"Because of the shortcomings identified and having only partial access to appendices with no access to case report forms, the harms could not be estimated accurately," the authors write. "To elucidate the harms reliably, access to anonymized individual patient data is needed."

Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Dietary changes, other meds, and even surgery can lower cardiovascular risk similarly to statins

Negative Effects Seen With Video Gaming 9 Hours/Week

Negative Effects Seen With Video Gaming 9+ Hours/Week

Benefits seen with one hour a week, but behavioral problems appear to rise at nine hours a week

Improved Adult Lung Function Linked to Childhood Farm Life

Improved Adult Lung Function Linked to Childhood Farm ...

First study to report beneficial effects of growing up on a farm on adult FEV1

is free, fast, and customized just for you!

Already a member?

Sign In Now »